These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24047693)

  • 1. SAD-A and AMPK kinases: the "yin and yang" regulators of mTORC1 signaling in pancreatic β cells.
    Nie J; Han X; Shi Y
    Cell Cycle; 2013 Nov; 12(21):3366-9. PubMed ID: 24047693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SAD-A kinase controls islet β-cell size and function as a mediator of mTORC1 signaling.
    Nie J; Liu X; Lilley BN; Zhang H; Pan YA; Kimball SR; Zhang J; Zhang W; Wang L; Jefferson LS; Sanes JR; Han X; Shi Y
    Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13857-62. PubMed ID: 23922392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTORC1 to AMPK switching underlies β-cell metabolic plasticity during maturation and diabetes.
    Jaafar R; Tran S; Shah AN; Sun G; Valdearcos M; Marchetti P; Masini M; Swisa A; Giacometti S; Bernal-Mizrachi E; Matveyenko A; Hebrok M; Dor Y; Rutter GA; Koliwad SK; Bhushan A
    J Clin Invest; 2019 Jul; 129(10):4124-4137. PubMed ID: 31265435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMPK and Friends: Central Regulators of β Cell Biology.
    Rourke JL; Hu Q; Screaton RA
    Trends Endocrinol Metab; 2018 Feb; 29(2):111-122. PubMed ID: 29289437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The miR-17~92 cluster activates mTORC1 in mantle cell lymphoma by targeting multiple regulators in the STK11/AMPK/TSC/mTOR pathway.
    Jiang C; Bi C; Jiang X; Tian T; Huang X; Wang C; Fernandez MR; Iqbal J; Chan WC; McKeithan TW; Lewis RE; Fu K
    Br J Haematol; 2019 May; 185(3):616-620. PubMed ID: 30198569
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeting deregulated AMPK/mTORC1 pathways improves muscle function in myotonic dystrophy type I.
    Brockhoff M; Rion N; Chojnowska K; Wiktorowicz T; Eickhorst C; Erne B; Frank S; Angelini C; Furling D; Rüegg MA; Sinnreich M; Castets P
    J Clin Invest; 2017 Feb; 127(2):549-563. PubMed ID: 28067669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Kinase-Dead mTOR Impairs Glucose Homeostasis by Regulating Insulin Secretion and Not β-Cell Mass.
    Alejandro EU; Bozadjieva N; Blandino-Rosano M; Wasan MA; Elghazi L; Vadrevu S; Satin L; Bernal-Mizrachi E
    Diabetes; 2017 Aug; 66(8):2150-2162. PubMed ID: 28546423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key Markers of mTORC1-Dependent and mTORC1-Independent Signaling Pathways Regulating Protein Synthesis in Rat Soleus Muscle During Early Stages of Hindlimb Unloading.
    Mirzoev T; Tyganov S; Vilchinskaya N; Lomonosova Y; Shenkman B
    Cell Physiol Biochem; 2016; 39(3):1011-20. PubMed ID: 27536969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diosgenin reduces phosphodiesterase 3B (PDE3B) through AMP-activated protein kinase/ mechanistic target of rapamycin (AMPK/mTOR) signaling pathway to ameliorate streptozotocin-induced pancreatic β-cell apoptosis and dysfunction.
    Ma L; Zhang C; Wu L; Qin L; Liu T
    Bioengineered; 2022 Feb; 13(2):2217-2225. PubMed ID: 35030973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMPK--sensing energy while talking to other signaling pathways.
    Hardie DG
    Cell Metab; 2014 Dec; 20(6):939-52. PubMed ID: 25448702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes.
    Yuan T; Rafizadeh S; Gorrepati KD; Lupse B; Oberholzer J; Maedler K; Ardestani A
    Diabetologia; 2017 Apr; 60(4):668-678. PubMed ID: 28004151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex.
    Howell JJ; Hellberg K; Turner M; Talbott G; Kolar MJ; Ross DS; Hoxhaj G; Saghatelian A; Shaw RJ; Manning BD
    Cell Metab; 2017 Feb; 25(2):463-471. PubMed ID: 28089566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMPK Regulation of Cell Growth, Apoptosis, Autophagy, and Bioenergetics.
    Villanueva-Paz M; Cotán D; Garrido-Maraver J; Oropesa-Ávila M; de la Mata M; Delgado-Pavón A; de Lavera I; Alcocer-Gómez E; Álvarez-Córdoba M; Sánchez-Alcázar JA
    Exp Suppl; 2016; 107():45-71. PubMed ID: 27812976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lysosome: a crucial hub for AMPK and mTORC1 signalling.
    Carroll B; Dunlop EA
    Biochem J; 2017 Apr; 474(9):1453-1466. PubMed ID: 28408430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factor-7-like 2 (
    Nguyen-Tu MS; da Silva Xavier G; Leclerc I; Rutter GA
    J Biol Chem; 2018 Sep; 293(36):14178-14189. PubMed ID: 29967064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum- and glucocorticoid-induced kinase drives hepatic insulin resistance by directly inhibiting AMP-activated protein kinase.
    Zhou B; Zhang Y; Li S; Wu L; Fejes-Toth G; Naray-Fejes-Toth A; Soukas AA
    Cell Rep; 2021 Oct; 37(1):109785. PubMed ID: 34610303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antiglioma action of indomethacin is mediated via AMP-activated protein kinase/mTOR complex 1 signalling pathway.
    Pantovic A; Bosnjak M; Arsikin K; Kosic M; Mandic M; Ristic B; Tosic J; Grujicic D; Isakovic A; Micic N; Trajkovic V; Harhaji-Trajkovic L
    Int J Biochem Cell Biol; 2017 Feb; 83():84-96. PubMed ID: 27988363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anorexigenic and orexigenic hormone modulation of mammalian target of rapamycin complex 1 activity and the regulation of hypothalamic agouti-related protein mRNA expression.
    Watterson KR; Bestow D; Gallagher J; Hamilton DL; Ashford FB; Meakin PJ; Ashford ML
    Neurosignals; 2013; 21(1-2):28-41. PubMed ID: 22456226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liraglutide regulates lipid metabolism via FGF21- LKB1- AMPK- ACC1 pathway in white adipose tissues and macrophage of type 2 diabetic mice.
    Zhang N; Liu C; Zhang Y; Xu D; Gui L; Lu Y; Zhang Q
    Biochem Biophys Res Commun; 2021 Apr; 548():120-126. PubMed ID: 33640604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systems study reveals concurrent activation of AMPK and mTOR by amino acids.
    Dalle Pezze P; Ruf S; Sonntag AG; Langelaar-Makkinje M; Hall P; Heberle AM; Razquin Navas P; van Eunen K; Tölle RC; Schwarz JJ; Wiese H; Warscheid B; Deitersen J; Stork B; Fäßler E; Schäuble S; Hahn U; Horvatovich P; Shanley DP; Thedieck K
    Nat Commun; 2016 Nov; 7():13254. PubMed ID: 27869123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.